✦ LIBER ✦

Factors influencing adolescent and parent decisions to enroll in a randomized placebo controlled asthma research trial

✍ Scribed by Janet L. Brody; David G. Scherer; Robert D. Annett

Book ID: 116592606
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 39 KB
Volume: 36
Category: Article
ISSN: 1054-139X
DOI: 10.1016/j.jadohealth.2004.11.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of psychological factors on p

The impact of psychological factors on placebo responses in a randomized controlled trial comparing sham device to dummy pill

✍ Suzanne M. Bertisch; Anna R. T. Legedza; Russell S. Phillips; Roger B. Davis; Wi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Allergic factors associated with the dev

Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: First results of ETA®

✍ Prof. Ulrich Wahn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

Atacicept in patients with rheumatoid ar

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial

✍ M. C. Genovese; N. Kinnman; G. de La Bourdonnaye; C. Pena Rossi; P. P. Tak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 2 views

Epimedium-derived flavonoids exert benef

Epimedium-derived flavonoids exert beneficial intervention effects on both skeletal and non-skeletal factors related to hip fracture risk in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial

✍ Ge Zhang; Ling Qin; Yinyu Shi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Assessment of antibodies to double-stran

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

✍ P. J. Charles; R. J. T. Smeenk; J. De Jong; M. Feldmann; R. N. Maini 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Objective. To compare the incidence of antidouble-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor ␣ (anti-TNF␣) antibody or placebo infusions, with or without methotrexate, in open-label, ra

Granulocyte–macrophage colony-stimulatin

Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

✍ Thomas, X; Fenaux, P; Dombret, H; Delair, S; Dreyfus, F; Tilly, H; Vekhoff, A; C 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB